David Pointer

Check out our meta-analysis on the prognostic role of biliary spillage during index cholecystectomy in #GallBladderCancer from @Tulane_Surgery @JeffDemond @DrAdarshVijay @DavidPointerMD @JSurgRes @AsianAcadSurg sciencedirect.com/science/articl…

Blake Cady’s original “Biology Is King” paper. Principals Of Oncology. A must read for all cancer doctors. ⁦@TheNotoriousHPB⁩ ⁦@SWexner⁩ ⁦@NirajGusani⁩ ⁦@TsengJennifer⁩ ⁦@mkatzmd⁩ ⁦@DrJashDatta⁩ ⁦@HalletJulie⁩

We are proud to announce Ochsner Health has partnered with @MDAndersonNews to create Ochsner MD Anderson Cancer Center! This partnership will give patients access to cancer treatments that are among the most advanced in the nation. Learn more at ochsner.org/cancerservices #EndCancer

May is Melanoma and Skin Cancer Awareness Month. Melanoma is the third most common type of skin cancer. It is especially dangerous because it can invade other organs quickly if it isn’t treated at an early stage. Learn the best ways to protect your skin: blog.ochsner.org/articles/am-i-…

@GolfDigest @JDayGolf I no Woo

For the first time since 2018, Jason Day is back in the winner's circle! 🏆

Our @OchsnerCancer team had a fantastic morning at #PanCANPurpleStride walking for all of the patients and families we care for every day! @PanCAN @OchsnerHealth @jonmizrahi

Congrats @DougSlakey !!

This week’s venous reconstructions covered the gamut. Thought an IJ interposition would be necessary for a 3.5cm resection of the PV/SMV confluence…amazing what is amenable to a primary anastomosis after liver mobilization and Cattell-Braasch. @AHPBA @SocSurgOnc @PancreasClub

Grateful to be named as a 2022 @CastleConnolly #RisingStar in Surgery @Tulane_Surgery! Excited for the next chapter @OchsnerHealth @OchsnerCancer castleconnolly.com/rising-star-aw…

Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma ja.ma/3pi5M2h via @JAMASurgery part of @JAMANetwork. Great work MSLT2 collaborative group led by @MarkFariesMD

@JustinWilkesMD 💯

Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II - PubMed. pubmed.ncbi.nlm.nih.gov/35703962/

Well deserved!

Expert view: Sharven Taghavi, MD, Tulane trauma and critical care surgeon on gun violence. medicine.tulane.edu/news/expert-vi…

Congratulations to @OncologyUab Assistant Professor Dr. @KristyBroman for earning the 2022 @ConquerCancerFd Career Development Award! This prestigious award will fund Broman $200,000 over three years for research. Read more: uab.edu/medicine/surge…

MAJOR congratulations to Dr. Sarah Hoffe and her team on their 18(!!) @tellyawards this year! She is at the forefront of creating novel and innovative #PatientEducation and #Leadership videos! tellyawards.com/?s=moffitt+can… @MoffittNews @RinglingCollege @roecsg @ARRO_org @ACROresident

Great job @KavinSugumar !

Inspiring talk from a trailblazer in surgery, Dr. Marleta Reynolds- after a 2 year delay- the Tulane Surgical Society honored alum! Oh and … first woman to complete the @Tulane_Surgery residency in 1981!!#looklikeasurgeon

@JohnEMullinaxMD @SocSurgOnc @MoffittNews @SeanP_Dineen @AGangiMD I’ll be there!

Calling all #MoffittCGSO alumni: we’ll have our reunion dinner at Meso Maya in Dallas during the ⁦@SocSurgOnc⁩ meeting, hosted by Vern Sondak. DM for details and spread the word. ⁦@MoffittNews⁩ ⁦@SeanP_Dineen⁩ ⁦⁦⁩ ⁦@AGangiMD⁩

The prospective PLASTIC study found that, for staging locally advanced gastric cancer, FDG-PET/CT has limited additive value as it detects metastatic disease in only 3%. Staging laparoscopy adds considerably as it detects non-curable disease in 19% ja.ma/31Dcesg

Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis journals.lww.com/annalsofsurger…